Energy substrate metabolism in cardiac hypertrophy

Area of Science:

• Cardiovascular Physiology and Metabolism
• Molecular Cardiology
• Cellular Adaptation

Background:

• Cardiac hypertrophy results from prolonged hemodynamic overload, either pathologic (e.g., hypertension) or physiologic (e.g., exercise).
• This adaptation involves significant alterations in how the heart utilizes energy substrates, leading to distinct metabolic phenotypes.

Purpose of the Study:

• To investigate the differential patterns of energy substrate utilization in cardiac hypertrophy.
• To understand how the nature of the hemodynamic stimulus (pathologic vs. physiologic) influences the cardiac metabolic phenotype.
• To explore the mechanisms underlying metabolic adaptations and their impact on cardiac resilience.

Main Methods:

• Comparative analysis of substrate utilization (fatty acid and glucose oxidation, glycolysis) in models of pathologic and physiologic cardiac hypertrophy.
• Examination of alterations in the expression and post-translational modification of key metabolic enzymes and proteins.

Main Results:

• Cardiac hypertrophy exhibits distinct metabolic phenotypes based on the stimulus; pathologic and physiologic hypertrophy show opposite changes in fatty acid and glucose oxidation.
• Metabolic alterations are adaptive but can compromise cardiac resilience to stress (e.g., ischemia-reperfusion) in pathologic hypertrophy.
• Differences in metabolic phenotypes are attributed to both altered gene/protein expression and post-translational modifications of metabolic enzymes.

Conclusions:

• The metabolic response to cardiac hypertrophy is stimulus-dependent, not stereotypical.
• Understanding these distinct metabolic phenotypes is crucial for developing strategies to enhance cardiac functional resiliency, particularly in pathologic conditions.
• Both transcriptional and post-translational regulatory mechanisms contribute to the metabolic reprogramming in cardiac hypertrophy.